Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company develops next-generation adeno-associated virus (AAV) gene delivery vectors through capsid modification. These modified AAV vectors provide precise and safe in vivo gene delivery for gene therapy applications.